Previously, the authors identified a heterodimer of the alpha and beta chains of hemoglobin in the brain microenvironment that killed brain‐metastasizing melanoma cells by targeting BRD4 and IRS2 proteins. This evidence concerns the gene BRD4 and melanoma.